The Cancer Consortium

Cancer News & Information Center

Sunday, October 25th, 2026

Menu

  • Home
  • Members
    • Travera
    • Soligenix (SNGX)
    • NuView Life Sciences
  • News
    • MEMBER NEWS
    • FINDINGS
    • INDUSTRY
  • INTERVIEWS
    • CEOs
    • KOLs
  • Cancer Types
    • Breast Cancer
    • Cervical Cancer
    • Head and Neck Cancer
  • Database
  • About
    • Altru Cancer
    • Cancer Consortium
    • Newsletter
    • Research
  • RESOURCES
    • Foundations
    • Patient Resources
    • Media Resources

Seno Medical Uses Laser-Based Technology For Early cancer Diagnosis

By Global Cancer Consortium on February 13, 2011 • ( 1 Comment )

Seno Medical is a company focused on cancer using its new patented opto-acoustic technology.  This new imaging modality combines the use of light in and sound out to uniquely obtain the hallmark […]

T-Ray Science Announces Name Change

By Global Cancer Consortium on February 11, 2011 • ( Leave a comment )

T-Ray Science, Inc., a medical device company committed to commercializing innovative systems for the early detection of cancer announces that shareholders approved a change of the name of the Company to Verisante Technology, Inc.

Hunting Disease In The Dark: MEDomics Seeks to Treat Mitochondrial Disease Before It Occurs

By Global Cancer Consortium on February 9, 2011 • ( 3 Comments )

The core theory behind preventative medicine is almost psychic. To stop a disease from wielding its mighty weapons before it occurs is based on foreknowledge of a patient’s susceptibility to the illness.

ADVENTRX Pharmaceuticals Takes the Next Step In Approval of ANX-530

By Global Cancer Consortium on January 24, 2011 • ( 1 Comment )

ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX), with its leading innovations in anti-cancer drug development has just announced that they have been successful in sending their ANX-530 (Exelbine) New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) with a Prescription Drug User Fee Act (PDUFA) date of September 1, 2011.

Oncology Panel Selected in OneMedForum SF 2011

By Global Cancer Consortium on December 10, 2010 • ( Leave a comment )

Over 500,000 people will die from cancer in the United States this year. There are many companies developing diagnostics for early detection and advanced therapies to address the various types of cancer.

NYSSA Announces Presenter List for Upcoming Biotech Conference

By Global Cancer Consortium on November 26, 2010 • ( Leave a comment )

The New York Society of Security Analysts, a leading forum for the investment community, recently announced the presenter list for its 14th Annual Biotech and Specialty Pharma Conference.

Brean Murray, Carret & Co. Host 2010 China Growth Conference

By Global Cancer Consortium on November 23, 2010 • ( Leave a comment )

The Chinese market is booming and everyone wants a piece of the pie. China is not only the world’s second largest economy after the United States by purchasing power parity but is also the world’s fastest-growing major economy, with average growth rates of 10% for the past 30 years.

Blood Tests Can Enable Early Cancer Diagnosis

By Global Cancer Consortium on November 19, 2010 • ( Leave a comment )

Scientists have yet to find the magic cure for cancer, but they may have found a way to beat it at its own game.

Posts navigation

‹ Newer 1 … 45 46 47 48 49 50 51 52 53 54 55 … 84 Older ›

INTERVIEWS »

INTERVIEW: Travera CEO Clifford Reid PhD

INTERVIEW: Soligenix CEO Christopher Schaber PhD.

INTERVIEW: Biden Cancer Initiative’s Greg Simon

PROFILES »

Gray Scale Images Convert to Detailed Color Images to Better Diagnose Breast Cancer

New Technology Using Light Therapy Kills Cells with No Side Effects

Real-time, In vivo Imaging Platform to Guide Surgeon During Cancer Surgery

Image result for cancer commons

Cancer Progress Report

Altru Cancer Progress Report June 2019

Subscribe to Cancer Progress Report

 

 

About Cancer Consortium

Members of the Global Cancer Consortium believe that progress occurs through collaboration which can occur through improved information.

This news site aggregates information and profiles of the member companies and organizations.

Its Cancer Progress Report reaches thousands of investors and industry professionals.

Global Cancer Consortium

The Cancer Consortium was formed by the Altru Cancer Project to offer one place to learn about the most promising developments, technologies and companies focused on Cancer.

 

 

  • Top categories: COMPANIES / cancer / Blog / feature2 / NEWS / Featured Articles / MEMBER NEWS / feature1 / Uncategorized / Member Spotlight
  • Top tags: cancer / breast cancer / diagnostics / oncology / prostate cancer / clarient / peter winter / brain cancer / melanoma / immunotherapy
Proudly powered by WordPress | Theme: Broadsheet by Pro Theme Design.